IGF2BP2 and nasopharyngeal carcinoma: This suggests that IGF2BP2 serves as a reader for METTL14‐mediated m6A modification on ANKRD22, thereby enhancing the stability and translation efficiency of ANKRD22 mRNA and contributing to its upregulation in NPC tissues.